Enhanced Chemotherapeutic Behavior of Open-Caged DNA at Doxorubicin Nanostructures for Cancer Cells

Journal of Cellular Physiology

Volumn 231, Issue 1, 2016, Pages 106-110

  Kumar, Vinit ^a   Bayda, Samer ^a,b   Hadla, Mohamad ^a,c   Caligiuri, Isabella ^a   Russo Spena, Concetta ^a   Palazzolo, Stefano ^a,b   Kempter, Susanne ^d   Corona, Giuseppe ^a   Toffoli, Giuseppe ^a   Rizzolio, Flavio ^a  

^a National Cancer Institute and Center for Molecular Biomedicine   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; DOXORUBICIN; NANOMATERIAL; DNA ADDUCT; DOXORUBICIN-DNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL VIABILITY ASSAY; CYTOTOXICITY; DNA SEQUENCE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; NATIVE POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; BREAST NEOPLASMS; DNA ADDUCT; DRUG DELIVERY SYSTEM; GENETICS; PROCEDURES; THERAPEUTIC USE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DNA ADDUCTS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; NANOSTRUCTURES;

EID: 84942342255     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25057     Document Type: Article

References (20)

1. Agrawal P, Barthwal SK, Barthwal R. 2009. Studies on self-aggregation of anthracycline drugs by restrained molecular dynamics approach using nuclear magnetic resonance spectroscopy supported by absorption, fluorescence, diffusion ordered spectroscopy and mass spectrometry. Eur J Med Chem 44:1437-1451.
2. Bhatia D, Surana S, Chakraborty S, Koushika SP, Krishnan Y. 2011. A synthetic icosahedral DNA-based host-cargo complex for functional in vivo imaging. Nat Commun 2:339.
3. Bhatia D, Mehtab S, Krishnan R, Indi SS, Basu A, Krishnan Y. 2009. Icosahedral DNA nanocapsules by modular assembly. Angew Chem Int Ed Engl 48:4134-4137.
4. Chang M, Yang C-S, Huang D-M. 2011. Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy. ACS Nano 5:6156-6163.
5. Conway JW, McLaughlin CK, Castor KJ, Sleiman H. 2013. DNA nanostructure serum stability: Greater than the sum of its parts. Chem Commun (Camb) 49:1172-1174.
6. Eckhardt S, Brunetto PS, Gagnon J, Priebe M, Giese B, Fromm KM 2013. Nanobio silver: its interactions with peptides and bacteria, and its uses in medicine. Chem Rev 113:4708-4754.
7. Gewirtz DA. 1999. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727-741.
8. Jiang Q, Song C, Nangreave J, Liu X, Lin L, Qiu D, Wang Z-G, Zou G, Liang X, Yan H, Ding B. 2012. DNA origami as a carrier for circumvention of drug resistance. J Am Chem Soc 134:13396-13403.
9. Karukstis KK, Thompson EH, Whiles JA, Rosenfeld RJ. 1998. Deciphering the fluorescence signature of daunomycin and doxorubicin. Biophys Chem 73:249-263.
10. Kim K-R, Kim D-R, Lee T, Yhee JY, Kim B-S, Kwon IC, Ahn D-R. 2013. Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells. Chem Commun (Camb) 49:2010-2012.
11. La Thangue NB, Kerr DJ. 2011. Predictive biomarkers: A paradigm shift towards personalized cancer medicine. Nat Rev Clin Oncol 8:587-596.
12. Li J, et al. 2013. Smart drug delivery nanocarriers with self-assembled DNA nanostructures. Adv Mater 25:4386-4396.
13. Liu H, Liu D. 2009. DNA nanomachines and their functional evolution. Chem Commun (Camb) 19:2625-2636.
14. Lewinski N, Colvin V, Drezek R. 2008. Cytotoxicity of nanoparticles. Small. 4:26-49.
15. Pinheiro AV, Han D, Shih WM, Yan H. 2011. Challenges and opportunities for structural DNA nanotechnology. Nat Nanotechnol 6:763-772.
16. Schüller VJ, Heidegger S, Sandholzer N, Nickels PC, Suhartha NA, Endres S, Bourquin C, Liedl T. 2011. Cellular immunostimulation by CpG-sequence-coated DNA origami structures. ACS Nano 5:9696-9702.
17. Tacar O, Sriamornsak P, Dass CR. 2013. Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65:157-170.
18. Visentin M, Simula MP, Sartor F, Petrucco A, De Re V, Toffoli G. 2009. Identification of proteins associated to multi-drug resistance in LoVo human colon cancer cells. Int J Clin Oncol 34:1281-1289.
19. Wang Z-G, Ding B. 2014. Engineering DNA self-assemblies as templates for functional nanostructures. Acc Chem Res 47:1654-1662.
20. Zhao Y-X, Shaw A, Zeng X, Benson E, Nyström AM, Högberg B. 2012. DNA origami delivery system for cancer therapy with tunable release properties. ACS Nano 6:8684-8691.